List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #4,341 to #4,390.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Antineutrophil cytoplasmic antibodies → Anti-neutrophil cytoplasmic antibody
  2. Antineutrophil cytoplasmic antibody → Anti-neutrophil cytoplasmic antibody
  3. Antinicotinic → Nicotinic antagonist
  4. Antinuclear Antibody → Antinuclear antibodies
  5. Antinuclear antibody → Anti-nuclear antibody
  6. Antinuclear factor → Anti-nuclear antibody
  7. Antiobesity → Anti-obesity drug
  8. Antioncogenic → Anticarcinogen
  9. Antioxid Caplets → Multivitamin
  10. Antioxidant Formula → Multivitamin
  11. Antioxidant Ultra Formula → Multivitamin
  12. Antioxidants → Antioxidant
  13. Antioxidants: WACS Study Demonstrates No Significant Benefit From Antioxidants For Preventing CVD → Special:Badtitle/NS100:Antioxidants: WACS Study Demonstrates No Significant Benefit From Antioxidants For Preventing CVD
  14. Antiparallel → Antiparallel (biochemistry)
  15. Antiparasitics → Antiparasitic
  16. Antiparkinsonian → Parkinson's disease
  17. Antiparkinsonism → Parkinson's disease
  18. Antiparticles → Antiparticle
  19. Antiperiplanar → Alkane stereochemistry
  20. Antiperspirant → Deodorant
  21. Antiphagocytic → Phagocytosis
  22. Antiphlogistic → Antipyretic
  23. Antiphospholipid-Antibody Syndrome (APL) → Antiphospholipid syndrome
  24. Antiphospholipid Antibody Syndrome → Antiphospholipid syndrome
  25. Antiphospholipid Syndrome → Antiphospholipid syndrome
  26. Antiphospholipid antibodies → Antiphospholipid syndrome
  27. Antiphospholipid antibody → Antiphospholipid syndrome
  28. Antiphospholipid antibody syndrome → Antiphospholipid syndrome
  29. Antiplatelet → Antiplatelet drug
  30. Antiplatelet Therapy to Support PCI (patient information) → Antiplatelet therapy to support PCI
  31. Antiplatelet agent → Antiplatelet drug
  32. Antiplatelet agents → Antiplatelet drug
  33. Antiplatelet therapy → Antiplatelet drug
  34. Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007 → Special:Badtitle/NS100:Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty 5 (ARMYDA-5) Presented Today at TCT 2007
  35. Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance → Special:Badtitle/NS100:Antiplatelets: Clopidogrel-to-Ticlopidine Crossover Study Demonstrates Drug Specific Resistance
  36. Antiporters → Antiporter
  37. Antiprotozoal → Antiprotozoal agent
  38. Antipsoriatics → Psoriasis
  39. Antipsychotic → Antipsychotics
  40. Antipsychotic (withdrawal) → Antipsychotics
  41. Antipsychotic agents → Antipsychotics
  42. Antipsychotic drugs → Antipsychotics
  43. Antipyretics → Antipyretic
  44. Antipyrine → Phenazone
  45. Antiretroviral → AIDS antiretroviral drugs
  46. Antiretroviral agent → AIDS antiretroviral drugs
  47. Antiretroviral drug → AIDS antiretroviral drugs
  48. Antiretroviral drugs → AIDS antiretroviral drugs
  49. Antiretroviral therapy → AIDS antiretroviral drugs
  50. Antiretroviral therapy in pregnancy → HIV and pregnancy#Treatment

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"